A Multi-Center Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-008-0807-6
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2008
Authors
Publisher
Springer Science and Business Media LLC